Detalhe da pesquisa
1.
The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.
Cardiovasc Diabetol
; 23(1): 13, 2024 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184612
2.
Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.
Diabet Med
; 41(6): e15320, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551152
3.
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
Int J Obes (Lond)
; 47(11): 1143-1151, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653071
4.
Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION-DK study.
Diabetes Obes Metab
; 25(9): 2595-2604, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272318
5.
Roux-en-Y gastric bypass versus sleeve gastrectomy: nationwide data from the Danish quality registry for treatment of severe obesity.
Surg Obes Relat Dis
; 18(4): 511-519, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082100
6.
The substantial costs to society associated with obesity - a Danish register-based study based on 2002-2018 data.
Expert Rev Pharmacoecon Outcomes Res
; 22(5): 823-833, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297718
7.
Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial.
BMJ Open
; 12(8): e054100, 2022 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953245
8.
Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
Surg Obes Relat Dis
; 14(5): 708-714, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29776493
9.
Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery.
EBioMedicine
; 28: 234-240, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29422288
10.
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.
Genome Med
; 8(1): 67, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27306058
11.
Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes.
Diabetol Metab Syndr
; 7: 12, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25763111
12.
Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.
J Obes
; 2013: 361781, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303210
13.
EMPA-REG: Glucose excretion and lipid mobilization - not storage - saves lives.
J Diabetes Complications
; 30(4): 753, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970674